HC Wainwright keeps Adagene price target at $7.00 per share
Dow Jones Newswires reports HC Wainwright kept its Adagene target at $7.00 and set a $4.50 target for Hadron Energy with a Buy rating.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Analysts at HC Wainwright & Co. maintained their price target on Adagene shares at $7.00 per share, Dow Jones Newswires reports. Separately, the broker set a $4.50 per share price target for Hadron Energy and initiated coverage of the company with a Buy rating.
The report relies on Benzinga data on analyst rating actions, and the text does not give the reasoning behind these decisions.
why it matters
Rating actions like these usually affect the share prices of individual companies and do little to change the broader market picture. For investors following Hadron Energy, the news adds a new analyst reference point for valuation, but it does not guarantee any move in the stock.
tags
instruments
sources
- Adagene Price Target Maintained With a $7.00/Share by HC Wainwright & Co. — Dow Jones Newswires, 19 October 2026 at 10:27 UTC
- Hadron Energy Price Target Announced at $4.50/Share by HC Wainwright & Co. — Dow Jones Newswires, 19 October 2026 at 10:25 UTC
- Crescent Biopharma Price Target Maintained With a $36.00/Share by HC Wainwright & Co. — Dow Jones Newswires, 19 October 2026 at 10:29 UTC
- Zentalis Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co. — Dow Jones Newswires, 19 October 2026 at 10:39 UTC
- Sol-Gel Technologies Price Target Maintained With a $110.00/Share by HC Wainwright & Co. — Dow Jones Newswires, 19 October 2026 at 10:43 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗